Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
1992.
Discounting health care: only a matter of timing?.
The Lancet,
Vol. 340,
Issue. 8812,
p.
148.
Johannesson, Magnus
1992.
Economic Evaluation of Hypertension Treatment.
International Journal of Technology Assessment in Health Care,
Vol. 8,
Issue. 3,
p.
506.
Johannesson, Magnus
and
Jönsson, Bengt
1993.
Economic evaluation of osteoporosis prevention.
Health Policy,
Vol. 24,
Issue. 2,
p.
103.
JOHANNESSON, M.
DAHLÖF, B.
LINDHOLM, L. H.
EKBOM, T.
HANSSON, L.
ODÉN, A.
SCHERSTÉN, B.
WESTER, P.‐O.
and
JÖNSSON, B.
1993.
The cost‐effectiveness of treating hypertension in elderly people—an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension).
Journal of Internal Medicine,
Vol. 234,
Issue. 3,
p.
317.
Johannesson, Magnus
Pliskin, Joseph S.
and
Weinstein, Milton C.
1994.
A Note on QALYs, Time Tradeoff, and Discounting.
Medical Decision Making,
Vol. 14,
Issue. 2,
p.
188.
Johannesson, Magnus
1994.
The Impact of Age on the Cost - Effectiveness of Hypertension Treatment.
Medical Decision Making,
Vol. 14,
Issue. 3,
p.
236.
Luce, Bryan R.
and
Simpson, Kit
1995.
Methods of cost-effectiveness analysis: areas of consensus and debate.
Clinical Therapeutics,
Vol. 17,
Issue. 1,
p.
109.
Karlberg, Ingvar
and
Nyberg, Gudrun
1995.
Cost-Effectiveness Studies of Renal Transplantation.
International Journal of Technology Assessment in Health Care,
Vol. 11,
Issue. 3,
p.
611.
Patterson, Randolph E.
1996.
Cost-effectiveness analysis in diagnosis of cardiac disease: Overview of its rationale and method.
Journal of Nuclear Cardiology,
Vol. 3,
Issue. 4,
p.
334.
Ménard, JoËL
1996.
Cost-Effectiveness of Hypertension Treatment.
Clinical and Experimental Hypertension,
Vol. 18,
Issue. 3-4,
p.
399.
Søgaard, Jes
and
Gyrd-Hansen, Dorte
1998.
Health, the Medical Profession, and Regulation.
Vol. 6,
Issue. ,
p.
51.
Biddle, AK
and
Simpson, KN
1999.
Modelling the cost-effectiveness of nevirapine triple combination therapy and dual combination therapy for the treatment of HIV disease in the United Kingdom.
Journal of Medical Economics,
Vol. 2,
Issue. 1-4,
p.
85.
Biddle, Andrea K.
and
Simpson, Kit N.
2000.
Modeling the Use of Triple Combination Therapy in Five Countries: Nevirapine, Zidovudine, and Didanosine.
Value in Health,
Vol. 3,
Issue. 3,
p.
186.
Wutzke, Sonia E
Shiell, Alan
Gomel, Michelle K
and
Conigrave, Katherine M
2001.
Cost effectiveness of brief interventions for reducing alcohol consumption.
Social Science & Medicine,
Vol. 52,
Issue. 6,
p.
863.
Rupp, Agnes
and
Sorel, Eliot
2001.
The Mental Health Consequences of Torture.
p.
89.
Capri, Stefano
Ceci, Adriana
Terranova, Lorenzo
Merlo, Franco
and
Mantovani, Lorenzo
2001.
Guidelines for Economic Evaluations in Italy: Recommendations from The Italian Group of Pharmacoeconomic Studies.
Drug Information Journal,
Vol. 35,
Issue. 1,
p.
189.
Bos, Jasper M
Beutels, Philippe
Annemans, Lieven
and
Postma, Maarten J
2004.
Valuing Prevention Through Economic Evaluation.
PharmacoEconomics,
Vol. 22,
Issue. 18,
p.
1171.
Bos, J M
Postma, Maarten J
and
Annemans, Lieven
2005.
Discounting Health Effects in Pharmacoeconomic Evaluations.
PharmacoEconomics,
Vol. 23,
Issue. 7,
p.
639.